Shiyan, 442000,
China
Sunflower Pharmaceutical Group Hubei Wudang Co. Technographics
Discover the latest software purchases and digital transformation initiatives being undertaken by Sunflower Pharmaceutical Group Hubei Wudang Co. and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 118 Sunflower Pharmaceutical Group Hubei Wudang Co. employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Sunflower Pharmaceutical Group Hubei Wudang Co. has purchased the following applications: UFIDA BIP Platform for Business Process Management in 2025 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Sunflower Pharmaceutical Group Hubei Wudang Co. is running and its propensity to invest more and deepen its relationship with Yonyou or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Sunflower Pharmaceutical Group Hubei Wudang Co. revenues, which have grown to $17.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Sunflower Pharmaceutical Group Hubei Wudang Co. intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
ERP Services and Operations
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Yonyou | Legacy | UFIDA BIP Platform | Business Process Management | ERP Services and Operations | n/a | 2025 | 2025 |
In 2025, Sunflower Pharmaceutical Group Hubei Wudang Co. entered a digital intelligence cooperation with vendor Yonyou and provisioned the UFIDA BIP Platform as a Business Process Management application to break through digital intelligence barriers across enterprise links. The decision frames the UFIDA BIP Platform as the core process backbone for enterprise-wide process orchestration and visibility.
Implementation focuses on workflow orchestration, process intelligence, and enterprise process visualization, using UFIDA BIP Platform capabilities to instrument and visualize end to end process flows. Configuration emphasizes business process modeling, data visualization of the entire process, and automated orchestration of sequential and parallel process steps consistent with Business Process Management functional patterns.
Operational coverage is described as spanning all links of the enterprise and driving digital intelligence across the entire business chain, positioning the platform to unify process data and enable decision oriented visibility. Governance implications include cross functional coordination to realize data visualization and intelligence driven workflows, and the stated outcome is that this initiative will help the company achieve its ultimate strategic goals.
|
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||